Lilly/Verge Pact Shows Resistance To Biopharma AI Is Futile

 
• By Alaric DeArment

Deal Snapshot: Following its diabetes deal with Biolojic by four months, Lilly’s partnership with Verge on using AI to discover ALS drugs is just the latest of numerous tech-biopharma tie-ups.

AI hand reaches
Eli Lilly and Verge announced a drug discovery and development deal centered on amyotrophic lateral sclerosis • Source: Shutterstock

More from Deals

More from Business